Thrombophilia in pregnancy: Whom to screen, when to treat

There is a prevailing need for a double-blind placebo-controlled trial to address these questions and evaluate the benefit of heparin in pregnant women with a history of adverse pregnancy outcomes and thrombophilia. Until then, screening and treatment for thrombophilia remain experimental in these women.

The authors report no financial relationships relevant to this article.